+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Rigel Pharmaceuticals Inc - logo

Rigel Pharmaceuticals is a clinical-stage biotechnology company that focuses on the therapeutic areas of immunology, oncology and immuno-oncology. Rigel’s current clinical programs include clinical trials of fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of a variety of diseases. It has been in trials for rheumatoid arthritis, autoimmune thrombocytopenia, lymphoma and others. In addition, Rigel also has two oncology product candidates in development. Founded in 1996, Rigel is headquartered in San Francisco, California.

Global SYK Inhibitors Market & Clinical Trials Outlook 2028 - Product Thumbnail Image

Global SYK Inhibitors Market & Clinical Trials Outlook 2028

  • Report
  • February 2023
  • 114 Pages
  • Global
From
Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures - Product Thumbnail Image

Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures

  • Report
  • May 2019
  • 385 Pages
  • Global
From
Chronic Kidney Disease Market: Pipeline Review, Developer Landscape and Competitive Insights - Product Thumbnail Image

Chronic Kidney Disease Market: Pipeline Review, Developer Landscape and Competitive Insights

  • Report
  • November 2018
  • 164 Pages
  • Global
From
Protein Inhibitors Market Report 2025 - Product Thumbnail Image

Protein Inhibitors Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Zika Virus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Zika Virus Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • January 2023
  • 318 Pages
  • Global
From
Extractables and Leachables Testing Services Market, 2018-2028 - Product Thumbnail Image

Extractables and Leachables Testing Services Market, 2018-2028

  • Report
  • September 2018
  • 200 Pages
  • Global
From
Thrombocytopenia - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Thrombocytopenia - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 602 Pages
  • Global
From
Chondrosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chondrosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 116 Pages
  • Global
From
Rigel Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Rigel Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • May 2025
  • 50 Pages
From
Comprehensive Report on Rigel Pharmaceuticals Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Rigel Pharmaceuticals Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Rigel Pharmaceuticals Inc (RIGL) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Rigel Pharmaceuticals Inc (RIGL) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • July 2024
  • 51 Pages
From
Rigel Pharmaceuticals, Inc. - Company Profile and SWOT Analysis - Product Thumbnail Image

Rigel Pharmaceuticals, Inc. - Company Profile and SWOT Analysis

  • SWOT Analysis
  • January 2024
  • 43 Pages
From
Loading Indicator